ETC
WST icon

Exchange Traded Concepts’s West Pharmaceutical WST Stock Holding History

Exchange Traded Concepts’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Hold
320
– – ﹤0.01% 1453
2026
Q1 		$80.2K Buy
320
+32
+11% +$7.96K ﹤0.01% 1401
2025
Q4 		$79.2K Sell
288
-25
-8% -$6.84K ﹤0.01% 1418
2025
Q3 		$82.1K Hold
313
– – ﹤0.01% 1269
2025
Q2 		$68.5K Sell
313
-18
-5% -$3.85K ﹤0.01% 1303
2025
Q1 		$74.1K Buy
331
+92
+38% +$25.4K ﹤0.01% 1210
2024
Q4 		$78.3K Buy
239
+38
+19% +$12K ﹤0.01% 1186
2024
Q3 		$60.3K Sell
201
-630
-76% -$193K ﹤0.01% 1184
2024
Q2 		$274K Sell
831
-2,151
-72% -$760K 0.01% 836
2024
Q1 		$1.18M Buy
2,982
+1,810
+154% +$670K 0.03% 407
2023
Q4 		$413K Buy
1,172
+1,043
+809% +$369K 0.01% 675
2023
Q3 		$48.4K Sell
129
-1,149
-90% -$444K ﹤0.01% 1037
2023
Q2 		$489K Buy
1,278
+265
+26% +$94.7K 0.01% 620
2023
Q1 		$351K Sell
1,013
-144
-12% -$42.1K 0.01% 673
2022
Q4 		$272K Buy
1,157
+114
+11% +$27K 0.01% 687
2022
Q3 		$257K Buy
1,043
+225
+28% +$68.5K 0.01% 654
2022
Q2 		$247K Sell
818
-7,611
-90% -$2.48M 0.01% 719
2022
Q1 		$3.46M Buy
8,429
+7,299
+646% +$2.86M 0.07% 154
2021
Q4 		$530K Buy
1,130
+505
+81% +$217K 0.01% 663
2021
Q3 		$265K Sell
625
-1,507
-71% -$635K 0.01% 714
2021
Q2 		$766K Buy
2,132
+532
+33% +$176K 0.02% 379
2021
Q1 		$451K Sell
1,600
-66
-4% -$18.9K 0.02% 599
2020
Q4 		$472K Buy
1,666
+101
+6% +$28.3K 0.02% 379
2020
Q3 		$430K Sell
1,565
-35
-2% -$9.26K 0.02% 334
2020
Q2 		$363K Buy
1,600
+1,562
+4,111% +$307K 0.06% 261
2020
Q1 		$6K Buy
38
+6
+19% +$924 ﹤0.01% 384
2019
Q4 		$5K Buy
+32
New +$4.66K ﹤0.01% 384

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Exchange Traded Concepts's WST Position: Q2 2026 in Review

Exchange Traded Concepts held its West Pharmaceutical (WST) position steady in Q2 2026 at 320 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #1453.

Exchange Traded Concepts first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.46M in Q1 2022. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Exchange Traded Concepts held 320 shares of West Pharmaceutical worth $115K as of Q2 2026.
  • Exchange Traded Concepts left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #1453 holding.
  • Exchange Traded Concepts first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • Exchange Traded Concepts's West Pharmaceutical position peaked at $3.46M in Q1 2022.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.